Regulation of Immune Responses by Galectin-3

Animal Lectins: A Functional View

Volumn , Issue , 2008, Pages 435-448

  Hsu, Daniel K ^a   Liu, Fu Tong ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 85028661944     PISSN: None     EISSN: None     Source Type: Book    
DOI: 10.1201/9781420006971-40     Document Type: Chapter

References (104)

1. Barondes SH, Castronovo V, Cooper DNW, Cummings RD, Drickamer K, Feizi T, Gitt MA, Hirabayashi J, Hughes C, Kasai K, Leffler H, Liu FT, Lotan R, Mercurio AM, Monsigny M, Pillai S, Poirer F, Raz A, Rigby PWJ, Rini JM, and Wang JL: Galectins: A family of animal b-galactoside-binding lectins [Letter to the Editor], Cell 1994, 76:597-598.
2. Cooper DN: Galectinomics: Finding themes in complexity, Biochim Biophys Acta 2002, 1572:209-231.
3. Kleiboeker SB: Sequence analysis of the fi ber genomic region of a porcine adenovirus predicts a novel fi ber protein, Virus Res 1995, 39:299-309.
4. Hsu DK, Zuberi R, and Liu FT: Biochemical and biophysical characterization of human recombinant IgE-binding protein, an S-type animal lectin, J Biol Chem 1992, 267:14167-14174.
5. Massa SM, Cooper DNW, Leffler H, and Barondes SH: L-29, an endogenous lectin, binds to glycoconjugate ligands with positive cooperativity, Biochemistry 1993, 32:260-267.
6. Ochieng J, Platt D, Tait L, Hogan V, Raz T, Carmi P, and Raz A: Structure-function relationship of a recombinant human galactoside-binding protein, Biochemistry 1993, 32:4455-4460.
7. Ahmad N, Gabius HJ, Andre S, Kaltner H, Sabesan S, Roy R, Liu B, Macaluso F, and Brewer CF: Galectin-3 precipitates as a pentamer with synthetic multivalent carbohydrates and forms heterogeneous cross-linked complexes, J Biol Chem 2004, 279:10841-10847.
8. Mehul B, Bawumia S, and Hughes RC: Cross-linking of galectin 3, a galactose-binding protein of mammalian cells, by tissue-type transglutaminase, FEBS Lett 1995, 360:160-164.
9. Mahoney S, Wilkinson M, Smith S, and Haynes LW: Stabilization of neurites in cerebellar granule cells by transglutaminase activity: Identifi cation of midkine and galectin-3 as substrates, Neurosci 2000, 101:141-155.
10. van den Brûle FA, Liu FT, and Castronovo V: Transglutaminase-mediated oligomerization of galectin-3 modulates human melanoma cell interactions with laminin, Cell Adhes Commun 1998, 5:425-435.
11. Rini JM and Lobsanov YD: New animal lectin structures, Curr Opin Struct Biol 1999, 9:578-584.
12. Hughes RC: Secretion of the galectin family of mammalian carbohydrate-binding proteins, Biochim Biophys Acta 1999, 1473:172-185.
13. Liu FT, Patterson RJ, and Wang JL: Intracellular functions of galectins, Biochim Biophys Acta 2002, 1572:263-273.
14. He J and Baum LG: Presentation of galectin-1 by extracellular matrix triggers T cell death, J Biol Chem2004, 279:4705-4712.
15. Nieminen J, Kuno A, Hirabayashi J, and Sato S: Visualization of galectin-3 oligomerization on the surface of neutrophils and endothelial cells using fl uorescence resonance energy transfer, J Biol Chem 2007, 282:1374-1383.
16. Timoshenko AV, Gorudko IV, Maslakova OV, Andre S, Kuwabara I, Liu FT, Kaltner H, and Gabius HJ: Analysis of selected blood and immune cell responses to carbohydrate-dependent surface binding of proto- and chimera-type galectins, Mol Cell Biochem 2003, 250:139-149.
17. Davidson PJ, Davis MJ, Patterson RJ, Ripoche MA, Poirier F, and Wang JL: Shuttling of galectin-3 between the nucleus and cytoplasm, Glycobiology 2002, 12:329-337.
18. Dagher SF, Wang JL, and Patterson RJ: Identifi cation of galectin-3 as a factor in pre-mRNA splicing, Proc Natl Acad Sci USA 1995, 92:1213-1217.
19. Wang JL, Gray RM, Haudek KC, and Patterson RJ: Nucleocytoplasmic lectins, Biochim Biophys Acta2004, 1673:75-93.
20. Delacour D, Cramm-Behrens CI, Drobecq H, Le Bivic A, Naim HY, and Jacob R: Requirement for galectin-3 in apical protein sorting, Curr Biol 2006, 16:408-414.
21. Chiariotti L, Salvatore P, Frunzio R, and Bruni CB: Galectin genes: Regulation of expression, Glycoconj J 2002, 19:441-449.
22. Acosta-Rodriguez EV, Montes CL, Motran CC, Zuniga EI, Liu FT, Rabinovich GA, and Gruppi A: Galectin-3 mediates IL-4-induced survival and differentiation of B cells: Functional cross-talk and implications during Trypanosoma cruzi infection, J Immunol 2004, 172:493-502.
23. Joo HG, Goedegebuure PS, Sadanaga N, Nagoshi M, von Bernstorff W, and Eberlein TJ: Expression and function of galectin-3, a beta-galactoside-binding protein in activated T lymphocytes, J Leukoc Biol2001, 69:555-564.
24. Fahrer AM, Konigshofer Y, Kerr EM, Ghandour G, Mack DH, Davis MM, and Chien YH: Attributes of gammadelta intraepithelial lymphocytes as suggested by their transcriptional profi le, Proc Natl Acad Sci USA 2001, 98:10261-10266.
25. Hsu DK, Hammes SR, Kuwabara I, Greene WC, and Liu FT: Human T lymphotropic virus-1 infection of human T lymphocytes induces expression of the b-galactose-binding lectin, galectin-3, Am J Pathol1996, 148:1661-1670.
26. Schröder HC, Ushijima H, Theis C, Sève AP, Hubert J, and Müller WEG: Expression of nuclear lectin carbohydrate-binding protein 35 in human immunodeficiency virus type 1-infected Molt-3 cells, J Acquir Immune Defi c Syndr Hum Retrovirol 1995, 9:340-348.
27. Fogel S, Guittaut M, Legrand A, Monsigny M, and Hébert E: The Tat protein of HIV-1 induces galectin-3 expression, Glycobiology 1999, 9:383-387.
28. Haines KA, Flotte TJ, Springer TA, Gigli I, and Thorbecke GJ: Staining of Langerhans cells with monoclonal antibodies to macrophages and lymphoid cells, Proc Natl Acad Sci USA 1983, 80:3448-3451.
29. Wollenberg A, De la Salle H, Hanau D, Liu FT, and Bieber T: Human keratinocytes release the endogenous b-galactoside-binding soluble lectin eBP (IgE-binding protein) which binds to Langerhans cells where it modulates their binding capacity for IgE glycoform, J Exp Med 1993, 178:777-785.
30. Smetana K, Holikova Z, Klubal R, Bovin NV, Dvoankova B, Bartkova J, Liu FT, and Gabius HJ: Coexpression of binding sites for A(B) histo-blood group trisaccharides with galectin-3 and lag antigen in human Langerhans cells, J Leukocyte Biol 1999, 6:644-649.
31. Vray B, Camby I, Vercruysse V, Mijatovic T, Bovin NV, Ricciardi-Castagnoli P, Kaltner H, Salmon I, Gabius HJ, and Kiss R: Up-regulation of galectin-3 and its ligands by Trypanosoma cruzi infection with modulation of adhesion and migration of murine dendritic cells, Glycobiology 2004, 14:647-657.
32. Krugluger W, Frigeri LG, Lucas T, Schmer M, Forster O, Liu FT, and Boltz-Nitulescu G: Galectin-3 inhibits granulocyte-macrophage colony-stimulating factor (GM-CSF)-driven rat bone marrow cell proliferation and GM-CSF-induced gene transcription, Immunobiology 1997, 197:97-109.
33. Le Marer N: Galectin-3 expression in differentiating human myeloid cells, Cell Biol Int 2000, 24:245-251.
34. Liu FT, Hsu DK, Zuberi RI, Kuwabara I, Chi EY, and Henderson WR, Jr.: Expression and function of galectin-3, a b-galactoside-binding lectin, in human monocytes and macrophages, Am J Pathol 1995, 147:1016-1029.
35. Dumic J, Lauc G, Hadzija M, and Flögel M: Transfer to in vitro conditions infl uences expression and intracellular distribution of galectin-3 in murine peritoneal macrophages, Z Naturforsch (C) 2000, 55:261-266.
36. Cherayil BJ, Chaitovitz S, Wong C, and Pillai S: Molecular cloning of a human macrophage lectin specifi c for galactose, Proc Natl Acad Sci USA 1990, 87:7324-7329.
37. Nangia-Makker P, Ochieng J, Christman JK, and Raz A: Regulation of the expression of galactosidebinding lectin during human monocytic differentiation, Cancer Res 1993, 53:1-5.
38. Kim K, Mayer EP, and Nachtigal M: Galectin-3 expression in macrophages is signaled by Ras/ MAP kinase pathway and up-regulated by modified lipoproteins, Biochim Biophys Acta 2003, 1641:13-23.
39. Abu-Amer Y and Bar-Shavit Z: Modulation of vitamin D increased H2O2 production and MAC-2 expression in the bone marrow-derived macrophages by estrogen, Calcif Tissue Int 1994, 55:29-32.
40. Reichert F and Rotshenker S: Galectin-3/MAC-2 in experimental allergic encephalomyelitis, Exp Neurol 1999, 160:508-514.
41. Pesheva P, Urschel S, Frei K, and Probstmeier R: Murine microglial cells express functionally active galectin-3 in vitro, J Neurosci Res 1998, 51:49-57.
42. Frigeri LG and Liu FT: Surface expresson of functional IgE binding protein, an endogenous lectin, on mast cells and macrophages, J Immunol 1992, 148:861-869.
43. Truong MT, Gruart V, Kusnierz JP, Papin JP, Loiseau S, Capron A, and Capron M: Human neutrophils express immunoglobulin E (IgE)-binding proteins (Mac-2/eBP) of the S-type lectin family: Role in IgEdependent activation, J Exp Med 1993, 177:243-248.
44. Truong MJ, Gruart V, Liu FT, Prin L, Capron A, and Capron M: IgE-binding molecules (Mac-2/eBP) expressed by human eosinophils Implication in IgE-dependent eosinophil cytotoxicity, Eur J Immunol1993, 23:3230-3235.
45. Clark AG, Chen S, Zhang H, Brady GF, Ungewitter EK, Bradley JK, Sackey FN, and Foster MH: Multifunctional regulators of cell growth are differentially expressed in anergic murine B cells, Mol Immunol 2007, 44:1274-1285.
46. Brewer CF, Miceli MC, and Baum LG: Clusters, bundles, arrays and lattices: Novel mechanisms for lectin-saccharide-mediated cellular interactions, Curr Opin Struct Biol 2002, 12:616-623.
47. Hsu DK and Liu FT: Regulation of cellular homeostasis by galectins, Glycoconj J 2004, 19:507-515.
48. Yang RY and Liu FT: Galectins in cell growth and apoptosis, Cell Mol Life Sci 2003, 60:267-276.
49. Fukumori T, Takenaka Y, Yoshii T, Kim HR, Hogan V, Inohara H, Kagawa S, and Raz A: CD29 and CD7 mediate galectin-3-induced type II T-cell apoptosis, Cancer Res 2003, 63:8302-8311.
50. Stillman BN, Hsu DK, Pang M, Brewer CF, Johnson P, Liu FT, and Baum LG: Galectin-3 and galectin-1 bind distinct cell surface glycoprotein receptors to induce T cell death, J Immunol 2006, 176:778-789.
51. Perillo NL, Pace KE, Seilhamer JJ, and Baum LG: Apoptosis of T cells mediated by galectin-1, Nature1995, 378:736-739.
52. Perillo NL, Uittenbogaart CH, Nguyen JT, and Baum LG: Galectin-1, an endogenous lectin produced by thymic epithelial cells, induces apoptosis of human thymocytes, J Exp Med 1997, 185:1851-1858.
53. Rabinovich G, Castagna L, Landa C, Riera CM, and Sotomayor C: Regulated expression of a 16-kD galectin-like protein in activated rat macrophages, J Leukocyte Biol 1996, 59:363-370.
54. Zubieta MR, Furman D, Barrio M, Bravo AI, Domenichini E, and Mordoh J: Galectin-3 expression correlates with apoptosis of tumor-associated lymphocytes in human melanoma biopsies, Am J Pathol2006, 168:1666-1675.
55. Hoyer KK, Pang M, Gui D, Shintaku IP, Kuwabara I, Liu FT, Said JW, Baum LG, and Teitell MA: An anti-apoptotic role for galectin-3 in diffuse large B-cell lymphomas, Am J Pathol 2004, 164:893-902.
56. Yang RY, Hsu DK, and Liu FT: Expression of galectin-3 modulates T cell growth and apoptosis, Proc Natl Acad Sci USA 1996, 93:6737-6742.
57. Hahn HP, Pang M, He J, Hernandez JD, Yang RY, Li LY, Wang X, Liu FT, and Baum LG: Galectin-1 induces nuclear translocation of endonuclease G in caspase- and cytochrome c-independent T cell death, Cell Death Differ 2004, 11:1277-1286.
58. Hsu DK, Yang RY, Yu L, Pan Z, Salomon DR, Fung-Leung WP, and Liu FT: Targeted disruption of the galectin-3 gene results in attenuated peritoneal infl ammatory responses, Amer J Pathol 2000, 156:1073-1083.
59. Yu F, Finley RL, Jr., Raz A, and Kim HR: Galectin-3 translocates to the perinuclear membranes and inhibits cytochrome c release from the mitochondria. A role for synexin in galectin-3 translocation, J Biol Chem 2002, 277:15819-15827.
60. Matarrese P, Tinari N, Semeraro ML, Natoli C, Iacobelli S, and Malorni W: Galectin-3 overexpression protects from cell damage and death by infl uencing mitochondrial homeostasis, FEBS Lett 2000, 473:311-315.
61. Yoshii T, Fukumori T, Honjo Y, Inohara H, Kim HR, and Raz A: Galectin-3 phosphorylation is required for its anti-apoptotic function and cell cycle arrest, J Biol Chem 2002, 277:6852-6857.
62. Takenaka Y, Fukumori T, Yoshii T, Oka N, Inohara H, Kim HR, Bresalier RS, and Raz A: Nuclear export of phosphorylated galectin-3 regulates its antiapoptotic activity in response to chemotherapeutic drugs, Mol Cell Biol 2004, 24:4395-4406.
63. Akahani S, Nangia-Makker P, Inohara H, Kim HRC, and Raz A: Galectin-3: A novel antiapoptotic molecule with a functional BH1 (NWGR) domain of Bcl-2 family, Cancer Res 1997, 57:5272-5276.
64. Muchmore SW, Sattler M, Liang H, Meadows RP, Harlan JE, Yoon HS, Nettesheim D, Chang BS, Thompson CB, Wong SL, Ng SL, and Fesik SW: X-ray and NMR structure of human Bcl-xL, an inhibitor of programmed cell death, Nature 1996, 381:335-341.
65. Seetharaman J, Kanigsberg A, Slaaby R, Leffler H, Barondes SH, and Rini JM: X-ray crystal structure of the human galectin-3 carbohydrate recognition domain at 2.1 Å resolution, J Biol Chem 1998, 273:13047-13052.
66. Califi ce S, Castronovo V, Bracke M, and Van Den Brule F: Dual activities of galectin-3 in human prostate cancer: Tumor suppression of nuclear galectin-3 vs tumor promotion of cytoplasmic galectin-3, Oncogene 2004, 23:7527-7536.
67. Hughes RC: Galectins as modulators of cell adhesion, Biochimie 2001, 83:667-676.
68. Kuwabara I and Liu FT: Galectin-3 promotes adhesion of human neutrophils to laminin, J Immunol1996, 156:3939-3944.
69. Sato S and Hughes RC: Binding specifi city of a baby hamster kidney lectin for H type I and II chains, polylactosamine glycans, and appropriately glycosylated forms of laminin and fi bronectin, J Biol Chem1992, 267:6983-6990.
70. Ochieng J, Warfield P, Green-Jarvis B, and Fentie I: Galectin-3 regulates the adhesive interaction between breast carcinoma cells and elastin, J Cell Biochem 1999, 75:505-514.
71. Hikita C, Vijayakumar S, Takito J, Erdjument-Bromage H, Tempst P, and Al-Awqati Q: Induction of terminal differentiation in epithelial cells requires polymerization of hensin by galectin 3, J Cell Biol2001, 151:1235-1146.
72. Ochieng J, Leite-Browning ML, and Warfield P: Regulation of cellular adhesion to extracellular matrix proteins by galectin-3, Biochem Biophys Res Commun 1998, 246:788-791.
73. Andre S, Kojima S, Yamazaki N, Fink C, Kaltner H, Kayser K, and Gabius HJ: Galectins-1 and -3 and their ligands in tumor biology Non-uniform properties in cell surface presentation and modulation of adhesion to matrix glycoproteins for various tumor cell lines, in biodistribution of free and liposomebound galectins and in their expression by breast and colorectal carcinomas with/without metastatic propensity, J Cancer Res Clin Oncol 1999, 125:461-474.
74. Dong S and Hughes RC: Macrophage surface glycoproteins binding to galectin-3 (Mac-2-antigen), Glycoconj J 1997, 14:267-274.
75. Villa-Verde DM, Silva-Monteiro E, Jasiulionis MG, Farias-De-Oliveira DA, Brentani RR, Savino W, and Chammas R: Galectin-3 modulates carbohydrate-dependent thymocyte interactions with the thymic microenvironment, Eur J Immunol 2002, 32:1434-1444.
76. Swarte VV, Mebius RE, Joziasse DH, Van den Eijnden DH, and Kraal G: Lymphocyte triggering via L-selectin leads to enhanced galectin-3-mediated binding to dendritic cells, Eur J Immunol 1998, 28:2864-2871.
77. Sato S, Ouellet N, Pelletier I, Simard M, Rancourt A, and Bergeron MG: Role of galectin-3 as an adhesion molecule for neutrophil extravasation during streptococcal pneumonia, J Immunol 2002, 168:1813-1822.
78. Jin R, Greenwald A, Peterson MD, and Waddell TK: Human monocytes recognize porcine endothelium via the interaction of galectin 3 and alpha-GAL, J Immunol 2006, 177:1289-1295.
79. Mataresse P, Fusco O, Tinari N, Natoli C, Liu FT, Semeraro ML, Malorni W, and Iacobelli S: Galectin-3 overexpression protects from apoptosis by improving cell adhesion properties, Int J Cancer 2000, 85:545-554.
80. Furtak V, Hatcher F, and Ochieng J: Galectin-3 mediates the endocytosis of beta-1 integrins by breast carcinoma cells, Biochem Biophys Res Commun 2001, 289:845-850.
81. Kimata H: Enhancement of IgE production in B cells by neutrophils via galectin-3 in IgE-associated atopic eczema/dermatitis syndrome, Int Arch Allergy Immunol 2002, 128:168-170.
82. Dong S and Hughes RC: Galectin-3 stimulates uptake of extracellular Ca2+ in human Jurkat T-cells, FEBS Lett 1996, 395:165-169.
83. Demetriou M, Granovsky M, Quaggin S, and Dennis JW: Negative regulation of T-cell activation and autoimmunity by Mgat5 N-glycosylation, Nature 2001, 409:733-779.
84. Frigeri LG, Zuberi RI, and Liu FT: eBP, a b-galactoside-binding animal lectin, recognizes IgE receptor (FceRI) and activates mast cells, Biochemistry 1993, 32:7644-7649.
85. Zuberi RI, Frigeri LG, and Liu FT: Activation of rat basophilic leukemia cells by eBP, an IgE-binding endogenous lectin, Cell Immunol 1994, 156:1-12.
86. Jeng KCG, Frigeri LG, and Liu FT: An endogenous lectin, galectin-3 (eBP/Mac-2), potentiates IL-1 production by human monocytes, Immunol Lett 1994, 42:113-116.
87. Yamaoka A, Kuwabara I, Frigeri LG, and Liu FT: A human lectin, galectin-3 (eBP/Mac-2), stimulates superoxide production by neutrophils, J Immunol 1995, 154:3479-3487.
88. Karlsson A, Follin P, Leffler H, and Dahlgren C: Galectin-3 activates the NADPH-oxidase in exudated but not peripheral blood neutrophils, Blood 1998, 91:3430-3438.
89. Almkvist J, Faldt J, Dahlgren C, Leffler H, and Karlsson A: Lipopolysaccharide-induced gelatinase granule mobilization primes neutrophils for activation by galectin-3 and formylmethionyl-Leu-Phe, Infect Immun 2001, 69:832-837.
90. Feuk-Lagerstedt E, Jordan ET, Leffler H, Dahlgren C, and Karlsson A: Identifi cation of CD66a and CD66b as the major galectin-3 receptor candidates in human neutrophils, J Immunol 1999, 163:5592-5598.
91. Almkvist J, Dahlgren C, Leffler H, and Karlsson A: Activation of the neutrophil nicotinamide adenine dinucleotide phosphate oxidase by galectin-1, J Immunol 2002, 168:4034-4041.
92. Cortegano I, delPozo V, Cardaba B, deAndres B, Gallardo S, delAmo A, Arrieta I, Jurado A, Palomino P, Liu FT, and Lahoz C: Galectin-3 down-regulates IL-5 gene expression on different cell types, J Immunol1998, 161:385-389.
93. Cortegano I, Del Pozo V, Cárdaba B, Arrieta I, Gallardo S, Rojo M, Aceituno E, Takai T, Verbeek S, Palomino P, Liu FT, and Lahoz C: Interaction between galectin-3 and FcgammaRII induces downregulation of IL-5 gene: implication of the promoter sequence IL-5REIII, Glycobiology 2000, 10:237-242.
94. Sano H, Hsu DK, Apgar JR, Yu L, Sharma BB, Kuwabara I, Izui S, and Liu FT: Critical role of galectin-3 in phagocytosis by macrophages, J Clin Invest 2003, 112:389-397.
95. Chen HY, Sharma BB, Yu L, Zuberi R, Weng IC, Kawakami Y, Kawakami T, Hsu DK, and Liu FT: Role of galectin-3 in mast cell functions: Galectin-3-defi cient mast cells exhibit impaired mediator release and defective JNK expression, J Immunol 2006, 177:4991-4997.
96. Sano H, Hsu DK, Yu L, Apgar JR, Kuwabara I, Yamanaka T, Hirashima M, and Liu FT: Human galectin-3 is a novel chemoattractant for monocytes and macrophages, J Immunol 2000, 165:2156-2164.
97. Colnot C, Ripoche MA, Milon G, Montagutelli X, Crocker PR, and Poirier F: Maintenance of granulocyte numbers during acute peritonitis is defective in galectin-3-null mutant mice, Immunology 1998, 94:290-296.
98. Zuberi RI, Hsu DK, Kalayci O, Chen HY, Sheldon HK, Yu L, Apgar JR, Kawakami T, Lilly CM, and Liu FT: Critical role for galectin-3 in airway infl ammation and bronchial hyperresponsiveness in a murine model of asthma, Am J Pathol 2004, 165:2045-2053.
99. del Pozo V, Rojo M, Rubio ML, Cortegano I, Cardaba B, Gallardo S, Ortega M, Civantos E, Lopez E, Martin-Mosquero C, Peces-Barba G, Palomino P, Gonzalez-Mangado N, and Lahoz C: Gene therapy with galectin-3 inhibits bronchial obstruction and infl ammation in antigen-challenged rats through interleukin-5 gene downregulation, Am J Respir Crit Care Med 2002, 166:732-737.
100. Lopez E, Del Pozo V, Miguel T, Sastre B, Seoane C, Civantos E, Llanes E, Baeza ML, Palomino P, Cardaba B, Gallardo S, Manzarbeitia F, Zubeldia JM, and Lahoz C: Inhibition of chronic airway infl ammation and remodeling by galectin-3 gene therapy in a murine model, J Immunol 2006, 176:1943-1950.
101. Bernardes ES, Silva NM, Ruas LP, Mineo JR, Loyola AM, Hsu DK, Liu FT, Chammas R, and Roque-Barreira MC: Toxoplasma gondii infection reveals a novel regulatory role for galectin-3 in the interface of innate and adaptive immunity, Am J Pathol 2006, 168:1910-1920.
102. Beatty WL, Rhoades ER, Hsu DK, Liu FT, and Russell DG: Association of a macrophage galactosidebinding protein with Mycobacterium-containing phagosomes, Cell Microbiol 2002, 4:167-176.
103. Hrdlickova-Cela E, Plzak J, Smetana K, Jr., Melkova Z, Kaltner H, Filipec M, Liu FT, and Gabius HJ: Detection of galectin-3 in tear fl uid at disease states and immunohistochemical and lectin histochemical analysis in human corneal and conjunctival epithelium, Br J Ophthalmol 2001, 85:1336-1340.
104. Ohshima S, Kuchen S, Seemayer CA, Kyburz D, Hirt A, Klinzing S, Michel BA, Gay RE, Liu FT, Gay S, and Neidhart M: Galectin 3 and its binding protein in rheumatoid arthritis, Arthritis Rheum 2003, 48:2788-2795.